Trial Profile
An exploratory study of the effects of imatinib on allergic inflammation following out of allergy season repeated nasal allergen challenge in subjects with seasonal allergic rhinitis sensitive to timothy grass pollen-an exploratory study of c-kit inhibition in allergic respiratory diseases
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Seasonal allergic rhinitis
- Focus Pharmacodynamics
- Sponsors Novartis
- 21 Jun 2007 Status change from recruiting to in progress
- 16 Feb 2007 New trial record.